Skip to content
healthcare.dev

Rabeprazole Sodium

NDC 76420-818, Rabeprazole Sodium, tablet, delayed release, from Asclemed USA, Inc..

Product NDC
76420-818
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208644
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-818 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RABEPRAZOLE SODIUM20 mg/1

Pharmacologic classes

Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
76420-818-307642008183030 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-818-30)
76420-818-607642008186060 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-818-60)
76420-818-907642008189090 TABLET, DELAYED RELEASE in 1 BOTTLE (76420-818-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3b6a25c2-fb61-4c86-9988-c6ffac7939c4

Use it

Look up 76420-818 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-818 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-818. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.